Abpro Holdings (ABPO) Other Working Capital Changes (2024 - 2025)
Abpro Holdings' (ABPO) quarterly Other Working Capital Changes came in at $570000.0 in Q1 2026, up 1561.54% YoY from $34305.6 in Q1 2025, and up 355.61% on a QoQ basis from -$223000.0 in Q4 2025.
Abpro Holdings (ABPO) Other Working Capital Changes (2024 - 2025) Analysis & Trends
Abpro Holdings (ABPO) has 3 years of Other Working Capital Changes data on file, last reported at $570000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 4.9% year-over-year to -$150000.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was -$456000.0 (up 19.43% YoY) and the FY2025 annual result came in at -$456000.0, up 19.43% from the prior year.
- Other Working Capital Changes steadied at -$150000.0 in Q3 2025, from -$150000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of -$138000.0 in Q1 2024 to a low of -$156000.0 in Q1 2025.
- A 3-year average of $93000.0 and a median of $2000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2025 — Other Working Capital Changes tumbled 6850.0% — and 2026, when it surged 1561.54%.
- Tracing ABPO's Other Working Capital Changes over 2 years: stood at -$145000.0 in 2024, then slipped by 3.45% to -$150000.0 in 2025.
- The last three Other Working Capital Changes figures came in at -$150000.0 (Q3 2025), -$150000.0 (Q2 2025), and -$156000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Abpro Holdings | 1.14 Mn | 1.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -150,000.00 |
| Sep 30, 2025 | -150,000.00 |
| Sep 30, 2025 | -150,000.00 |
| Jun 30, 2025 | -150,000.00 |
| Jun 30, 2025 | -150,000.00 |
| Jun 30, 2025 | -150,000.00 |
| Mar 31, 2025 | -156,000.00 |
| Mar 31, 2025 | -156,000.00 |
| Mar 31, 2025 | -156,000.00 |
| Dec 31, 2024 | -145,000.00 |
| Dec 31, 2024 | -145,000.00 |
| Dec 31, 2024 | -145,000.00 |
| Sep 30, 2024 | -143,000.00 |
| Sep 30, 2024 | -143,000.00 |
| Sep 30, 2024 | -143,000.00 |
| Jun 30, 2024 | -140,000.00 |
| Jun 30, 2024 | -140,000.00 |
| Jun 30, 2024 | -140,000.00 |
| Mar 31, 2024 | -138,000.00 |
| Mar 31, 2024 | -138,000.00 |